Pharmaceuticals

EpiCast Report: Myelofibrosis - Epidemiology Forecast to 2025

  • GLO796994
  • 77 Pages
  • November 2016
  • Pharmaceuticals
EpiCast Report: Myelofibrosis - Epidemiology Forecast to 2025

Summary

This report provides an overview of the risk factors, comorbidities, and the global and historical trends for myelofibrosis in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident and diagnosed prevalent cases of myelofibrosis, PMF, PET MF and PPV MF based on county-specific studies published in peer-reviewed journals. The diagnosed incident cases of PMF are further segmented by sex, age (40-49 years, 50-59 years, 60-69 years, 70-79 years, and ?80 years), mutations, and the international prognostic scoring system (IPSS) risk categorization. The diagnosed prevalent cases of PMF are further segmented by sex and age (40-49 years, 50-59 years, 60-69 years, 70-79 years, and ?80 years). GlobalData epidemiologists also provide sex-specific diagnosed incident and diagnosed prevalent cases of PET MF and PPV MF in the 7MM for the forecast period.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed incident cases of myelofibrosis (sum of the diagnosed incident cases of PMF and SMF) will increase from 3,791 cases in 2015 to 4,378 cases in 2025, at an Annual Growth Rate (AGR) of 1.55%. The US will have the highest number of diagnosed incident cases of myelofibrosis among the 7MM throughout the forecast period, while Japan will have the lowest.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases of myelofibrosis will increase from 27,896 cases in 2015 to 32,030 cases in 2025, at an AGR of 1.48%. The US will have the highest number of diagnosed prevalent cases of myelofibrosis among the 7MM throughout the forecast period, while Japan will have the lowest.

GlobalDatas forecast is strengthened by the use of peer-reviewed, country-specific publications, which provided the diagnosed incidence and diagnosed prevalence data for PMF, PET MF, and PPV MF in each market. In addition, to improve the comparability of the forecast diagnosed incident and diagnosed prevalent cases of PMF, PET MF, and PPV MF across markets, GlobalData epidemiologists used sources that provided uniform diagnostic criteria for these subcategories.

Scope

- The Myelofibrosis EpiCast Report provides an overview of the risk factors and global trends of myelofibrosis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident and diagnosed prevalent cases of myelofibrosis, primary myelofibrosis (PMF), post-essential thrombocytosis myelofibrosis (PET MF) and post-polycythemia vera myelofibrosis (PPV MF). Detailed segmentations of myelofibrosis are also provided.
- The myelofibrosis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Myelofibrosis EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global myelofibrosis market.
- Quantify patient populations in the global myelofibrosis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for myelofibrosis therapeutics in each of the markets covered.
- Identify the percentage of myelofibrosis prevalent cases by sex, age, mutations, and risk categorization.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

April 2018| $5370 | Pre Book Price:$4699

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

April 2018| $4995 | Pre Book Price:$4371

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

April 2018| $5370 | Pre Book Price:$4699

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

April 2018| $2850 | Pre Book Price:$2494

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

April 2018| $2850 | Pre Book Price:$2494

Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

April 2018| $2850 | Pre Book Price:$2494

2019 © Copyright Big Market Research

View Pricing >>